Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease
- Details
- Publication Year 2023-04-10,Volume 64,Issue #4,Page 1-4
- Journal Title
- Leukemia & Lymphoma
- Publisher
- Taylor & Frances
- Research Division(s)
- Blood Cells And Blood Cancer
- PubMed ID
- 37037568
- Publisher's Version
- https://doi.org/10.1080/10428194.2023.2197533
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-04-17 03:32:27
Last Modified: 2023-04-18 02:01:14